Available Until 2/17/2024

AMA/ASHP Pharmacogenomics Virtual Summit Series: Summit #2: Current State of Pharmacogenomics

Please note: This activity was given as a live webinar on February 17, 2021. If you claimed credit for that activity, you should not claim credit for this activity.

ACPE Activity Number: 0204-9999-21-005-H04-P
Release Date: 2/19/2021
Expiration Date, 2/17/2024
Activity Date:  February 17, 2021
Activity Type:  Knowledge-based
CE Credits: 2
Activity Fee:  Free of charge

Activity Overview

Gain insights into Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and the FDA perspective, and hear best practices from early adopters.


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

This activity was planned in cooperation with the American Medical Association.This continuing pharmacy and medical education activity is designed for healthcare professionals interested in pharmacogenomics. The activity is meant for audiences with all knowledge levels. 

Learning Objectives

After participating in this activity, participants should be able to:

  • Discuss the process for developing CPIC guidelines
  • Describe the FDA perspective on pharmacogenomics
  • Recognize differences between CPIC guidelines and FDA warning labels
  • Identify best practices from leading institutions in the field of pharmacogenomics

Schedule of Activities

  • Introduction
  • Development of CPIC Guidelines
  • FDA Perspective
  • Personalized Medicine Coalition: Gap Analysis
  • Current State: NorthShore
  • Current State: University of Florida
  • Current State: St. Jude Children's Research Hospital
  • Future Directions & Wrap-up
  • Q&A
  • Future Directions & Wrap-up


  • Moderator:
    • Ulrich Broeckel, M.D., Professor of Pediatrics, Medicine and Physiology and Chief of the Section of Genomics Pediatrics, Medical College of Wisconsin

  • Speakers:
    • Kelly E. Caudle, Pharm.D., Ph.D., BCPS, FCCP, Co-PI and Director, Clinical Pharmacogenetics Implementation Consortium (CPIC), St. Jude Children’s Research Hospital
    • Timothy T. Stenzel, M.D., Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, Food and Drug Administration
    • Larisa H. Cavallari, Pharm.D., BCPS, FCCP, Associate Professor and Director of the Center for Pharmacogenomics at the University of Florida (UF) College of Pharmacy and Director of the UF Health Precision Medicine Program
    • Daryl Pritchard, Ph.D., Senior Vice President, Science Policy, Personalized Medicine Coalition
    • Henry “Mark” Dunnenberger, Pharm.D., BCPS, Director, Pharmacogenomics, Center for Personalized Medicine, NorthShore University HealthSystem
    • Mary V. Relling, Pharm.D., BCPS, FCCP, Member and Endowed Chair, Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital


All planners, program chairs, presenters, reviewers and ASHP staff report no financial relationships relevant to this activity.


Methods and CE Requirements

This activity consists of one recorded webinar presentation.  This is a 6 part series. 

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline.   After the 60 day deadline, ASHP will no longer be able to award credit for this activity.